BTG3 and arthritic joint disease: Two-thirds of JIA patients present early onset JIA, starting before the age of 6 years, with either a polyarticular or more often an oligoarticular (i.e., less than five arthritis within the first 6 months) joint involvement pattern and, in most cases, presence of non-specific antinuclear antibody (ANA) [2].